Potent Neutralizing Humanized Antibody With Topical Therapeutic Potential Against HPV18-Related Cervical Cancer

Cervical cancer caused by human papillomavirus (HPV) infections is the fourth most common cancer in women worldwide. Current prophylactic HPV vaccines have achieved promising success in preventing HPV infection. However, still 570,000 new cases were reported in 2018. The current primary treatment fo...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Immunol
Päätekijät: Huang, Bilian, Zhu, Linjing, Wei, Hongxia, Shi, Haixia, Zhang, Doudou, Yuan, Huanyun, Luan, Linlin, Zheng, Nan, Xu, Shijie, Nawaz, Waqas, Hong, Ying, Wu, Xilin, Wu, Zhiwei
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2021
Aiheet:
Immunology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8264373/
https://ncbi.nlm.nih.gov/pubmed/34248960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.678318
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia